CN

Chaula Nayan Thakkar

Active Director Director DIN 07265213
DIN 07265213 First appointment Oct 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Chaula Nayan Thakkar

Data last updated:

Chaula Nayan Thakkar is a Director at Cibanova Life Sciences Private Limited (since 2015). The company operates in Healthcare. Cibanova Life Sciences Private Limited reported revenue of ₹1.75 Cr (FY 2025).

DIN 07265213
Primary Designation Director
Industry Healthcare
First Appointment 23 Oct 2015
Oldest Company Age 11 yrs
Largest company Cibanova Life Sciences Private Limited · ₹1.75 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20152015₹1.75 Cr (FY 2025)Active

Board colleagues of Chaula Nayan Thakkar

Directorship timeline

Open interactive timeline →
Cibanova Life Sciences Private Limited
Premium access

Shareholding and investment profile for Chaula Nayan Thakkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaula Nayan Thakkar

Chaula Nayan Thakkar currently holds 1 directorship: Cibanova Life Sciences Private Limited (Director, since 23 Oct 2015, revenue ₹1.75 Cr (FY 2025)).

Chaula Nayan Thakkar was first appointed on 23 Oct 2015 as Director at Cibanova Life Sciences Private Limited.

The current boards of Chaula Nayan Thakkar's companies include Nayankumar Natwarlal Thakkar (Cibanova Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available